ESSENCE 2: CyclASol for the Treatment of Signs and Symptoms of Dry Eye Disease (DED)
Clinical trial NCT04523129 · COMPLETED
Trial details
- NCT number
- NCT04523129
- Sponsor
- Novaliq GmbH
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-05
- Primary completion
- 2021-09-03
- Enrollment
- 834
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.